COVID-19 Updates

Amy Yixiao Tang, MD

Gender
Female
Language
English

Primary Specialty

Hematology/Oncology


Education

Board Certification
Am Bd Pediatrics (Sub: Pediatric Hematology-Oncology), American Board of Pediatrics
Medical School:
Augusta University (formerly MCG, Ga Regents Univ)
Residency:
Emory University School of Medicine
Fellowship:
Columbia University

Publications

Pubmed Profile

Network


Introduction

Dr. Tang joined Children’s Healthcare of Atlanta and Emory University as Assistant Professor of Pediatric Hematology in July 2017. She previously completed a three-year fellowship in pediatric hematology/oncology at Columbia University. Prior to her fellowship, she earned a medical degree from Medical College of Georgia–Augusta University, followed by her pediatrics residency training at Emory.

Dr. Tang has a broad clinical interest in general hematology and sickle cell disease, especially in disorders of iron metabolism, clinical treatment and management of sickle cell disease, transfusion-related iron overload, and best practices in transfusion therapy and related complications in sickle cell disease.

Dr. Tang grew up in metro Atlanta and feels very fortunate to be back home, working with a talented and supportive group of hematology providers, nurses and staff. Her patients and families continue to impress her with their strength and resilience, and she considers it a privilege to be part of their care.

In her spare time, Dr. Tang enjoys practicing yoga, hiking in the mountains, attending concerts and indoor gardening. She is also a fan of University of Georgia football and Atlanta United. She is excited to be a part of the Children’s team.

Focus of Practice

  • General benign hematology
  • Sickle cell disease

Areas of Interest

  • Transfusions in sickle cell disease
  • Disorders of iron metabolism

Locations

Aflac Cancer and Blood Disorders Center

Egleston Hospital, 1405 Clifton Road NE Atlanta, GA 30322 Get Directions 404-785-1112

Research & Publications

Sickle cell disease, transfusional iron overload, mechanisms behind red cell alloimmunization, pharmacologic therapies for treatment and management of sickle cell disease